Reviewed by PillSeek Editorial Team · Last updated
About This Medication
This medication is a Yellow Oval 16 mm, Film coated extended release tablet with imprint "661". It contains Ropinirole hydrochloride 12 mg; of Ropinirole hydrochloride[ropinirole];. This belongs to the Nonergot dopamine agonist pharmacologic class. It is manufactured by Actavis Pharma, Inc.. For details please contact your physician.
Basic Information
- Imprint
- 661
- Color
- Yellow
- Shape
- Oval
- Size
- 16 mm
Drug Information
- Strength
- Ropinirole hydrochloride 12 mg;
- Dosage Form
- Film coated extended release tablet
- RxCUI
- 824959
Pharmaceutical Classification
- Pharmacologic Class
- Nonergot dopamine agonist
Related Medications
Other drugs in the same class: Nonergot Dopamine Agonist
- Mirapexpramipexole dihydrochloride 0.125 mg;WHITE • ROUND
- MirapexPRAMIPEXOLE DIHYDROCHLORIDE 0.375 mg;WHITE • ROUND
- MirapexPRAMIPEXOLE DIHYDROCHLORIDE 0.75 mg;WHITE • ROUND
- Mirapexpramipexole dihydrochloride 1.5 mg;WHITE • ROUND
- MirapexPRAMIPEXOLE DIHYDROCHLORIDE 1.5 mg;WHITE • OVAL
- Mirapexpramipexole dihydrochloride 1 mg;WHITE • ROUND
- MirapexPRAMIPEXOLE DIHYDROCHLORIDE 2.25 mg;WHITE • OVAL
- Mirapexpramipexole dihydrochloride .250 mg;WHITE • OVAL
- MirapexPRAMIPEXOLE DIHYDROCHLORIDE 3 mg;WHITE • OVAL
- MirapexPRAMIPEXOLE DIHYDROCHLORIDE 4.5 mg;WHITE • OVAL
Ingredients
- Active Ingredients
- Ropinirole hydrochloride[ropinirole];
- Inactive Ingredients
- Silicon dioxide;croscarmellose sodium;castor oil;hypromelloses;lactose monohydrate;magnesium stearate;maltodextrin;titanium dioxide;ferric oxide yellow;polyethylene glycol, unspecified;polyvinyl alcohol, unspecified;talc;
Additional Information
- Manufacturer
- Actavis Pharma, Inc.
- Status (Rx/OTC)
- Rx
- Brand Names
- Requip
Browse Related Pills
⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.